At a glance
ClinicalIndex Comparison RecordN/ACompleted· 507 enrolled
Drug / intervention
BioMimics 3D Stentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multicentre Observational Study to Evaluate the BioMimics 3D Self-Expanding Stent System in the Treatment of Peripheral Arterial Disease: MIMICS-3D
In Brief
An observational study evaluating BioMimics 3D Stent for Peripheral Arterial Disease. Completed, enrolled 507 participants across 23 sites in 4 countries.
Detailed Summary
The MIMICS-3D study will evaluate safety, effectiveness and device performance within a real-world clinical population of patients undergoing femoropopliteal intervention.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease
CountriesBelgium, Germany, Netherlands, Sweden
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartSep 2016
First PostedSep 2016
Primary CompletionOct 2019
Study CompletionSep 2021
TodayJul 2026
First PostedSep 15, 2016
Enrollment StartSep 1, 2016
Primary CompletionOct 1, 2019
Study CompletionSep 1, 2021
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 9.8 years ago
Interventions
BioMimics 3D Stentdevice